Determine the Effect of Targeted High-definition Transcranial Direct Current Stimulation (tDCS) on Reducing Post-stroke Upper Limb Motor Impairments

Recruiting N/A Interventional Study
Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
30 (estimated)
Sponsor
Carle Foundation Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Significant motor impairments occur in 80% of individuals after moderate to severe stroke and impact the body side to the lesioned hemisphere. Typical motor impairments involve loss of dexterity with highly prevalent upper limb flexion synergy. Advances in treating flexion synergy impairments have been hampered by a lack of precision rehabilitation. Previous studies suggest and support the role of…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Paresis confined to one side, with substantial motor impairment of the paretic upper limb * Capacity to provide informed consent Exclusion Criteria: * Muscle tone abnormalities and motor or sensory impairment in the non-paretic limb * Severe wasting or contracture or signifi…
Contacts

Yuan Yang, PhD

217-244-5870

yuan.yang@carle.com

CONTACT

Sanjiv Jain, MD

217-383-3800

sanjiv.jain@carle.com

CONTACT